<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36992493</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>18</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>EV-A71 Mechanism of Entry: Receptors/Co-Receptors, Related Pathways and Inhibitors.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">785</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v15030785</ELocationID><Abstract><AbstractText>Enterovirus A71, a non-enveloped single-stranded (+) RNA virus, enters host cells through three stages: attachment, endocytosis and uncoating. In recent years, receptors/co-receptors anchored on the host cell membrane and involved in this process have been continuously identified. Among these, hSCARB-2 was the first receptor revealed to specifically bind to a definite site of the EV-A71 viral capsid and plays an indispensable role during viral entry. It actually acts as the main receptor due to its ability to recognize all EV-A71 strains. In addition, PSGL-1 is the second EV-A71 receptor discovered. Unlike hSCARB-2, PSGL-1 binding is strain-specific; only 20% of EV-A71 strains isolated to date are able to recognize and bind it. Some other receptors, such as sialylated glycan, Anx 2, HS, HSP90, vimentin, nucleolin and fibronectin, were discovered successively and considered as "co-receptors" because, without hSCARB-2 or PSGL-1, they are not able to mediate entry. For cypA, prohibitin and hWARS, whether they belong to the category of receptors or of co-receptors still needs further investigation. In fact, they have shown to exhibit an hSCARB-2-independent entry. All this information has gradually enriched our knowledge of EV-A71's early stages of infection. In addition to the availability of receptors/co-receptors for EV-A71 on host cells, the complex interaction between the virus and host proteins and various intracellular signaling pathways that are intricately connected to each other is critical for a successful EV-A71 invasion and for escaping the attack of the immune system. However, a lot remains unknown about the EV-A71 entry process. Nevertheless, researchers have been continuously interested in developing EV-A71 entry inhibitors, as this study area offers a large number of targets. To date, important progress has been made toward the development of several inhibitors targeting: receptors/co-receptors, including their soluble forms and chemically designed compounds; virus capsids, such as capsid inhibitors designed on the VP1 capsid; compounds potentially interfering with related signaling pathways, such as MAPK-, IFN- and ATR-inhibitors; and other strategies, such as siRNA and monoclonal antibodies targeting entry. The present review summarizes these latest studies, which are undoubtedly of great significance in developing a novel therapeutic approach against EV-A71.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Kanghong</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-5913-2767</Identifier><AffiliationInfo><Affiliation>Sino-German Biomedical Center, National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education &amp; Hubei Province), Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, Wuhan 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onintsoa Diarimalala</LastName><ForeName>Rominah</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Sino-German Biomedical Center, National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education &amp; Hubei Province), Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, Wuhan 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Chenguang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sino-German Biomedical Center, National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education &amp; Hubei Province), Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, Wuhan 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hanluo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Sino-German Biomedical Center, National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education &amp; Hubei Province), Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, Wuhan 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Yanhong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Sino-German Biomedical Center, National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education &amp; Hubei Province), Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, Wuhan 430068, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002213" MajorTopicYN="N">Capsid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">entry</Keyword><Keyword MajorTopicYN="N">inhibitors</Keyword><Keyword MajorTopicYN="N">receptors/co-receptors</Keyword><Keyword MajorTopicYN="N">signaling pathways</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36992493</ArticleId><ArticleId IdType="pmc">PMC10051052</ArticleId><ArticleId IdType="doi">10.3390/v15030785</ArticleId><ArticleId IdType="pii">v15030785</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zell R. Picornaviridae-the ever-growing virus family. Arch. Virol. 2018;163:299–317. doi: 10.1007/s00705-017-3614-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-017-3614-8</ArticleId><ArticleId IdType="pubmed">29058149</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P., Perera R., Cardosa J., Kuhn R.J., Rossmann M.G. Structure determination of enterovirus 71. Acta Crystallogr. D. Biol. Crystallogr. 2012;68:1217–1222. doi: 10.1107/S0907444912025772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444912025772</ArticleId><ArticleId IdType="pmc">PMC3489104</ArticleId><ArticleId IdType="pubmed">22948923</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang P., Liu Y., Ma H.C., Paul A.V., Wimmer E. Picornavirus morphogenesis. Microbiol. Mol. Biol. Rev. 2014;78:418–437. doi: 10.1128/MMBR.00012-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00012-14</ArticleId><ArticleId IdType="pmc">PMC4187686</ArticleId><ArticleId IdType="pubmed">25184560</ArticleId></ArticleIdList></Reference><Reference><Citation>Horsley E., Just E., Torres C., Huhtinen E., Forssman B., Slade R. Enterovirus 71 outbreak in Northern Sydney, 2013: Case series and initial response. J. Paediatr. Child Health. 2014;50:525–530. doi: 10.1111/jpc.12625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.12625</ArticleId><ArticleId IdType="pubmed">25041293</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong V., Mey C., Eloit M., Zhu H., Danet L., Huang Z., Zou G., Tarantola A., Cheval J., Perot P., et al. Molecular epidemiology of human enterovirus 71 at the origin of an epidemic of fatal hand, foot and mouth disease cases in Cambodia. Emerg. Microbes Infect. 2016;5:e104. doi: 10.1038/emi.2016.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2016.101</ArticleId><ArticleId IdType="pmc">PMC5113052</ArticleId><ArticleId IdType="pubmed">27651091</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W., Liao Q., Viboud C., Zhang J., Sun J., Wu J.T., Chang Z., Liu F., Fang V.J., Zheng Y., et al. Hand, foot, and mouth disease in China, 2008–2012: An epidemiological study. Lancet Infect. Dis. 2014;14:308–318. doi: 10.1016/S1473-3099(13)70342-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagaya I., Takayama R., Hagiwara A. A large-scale epidemic of hand, foot and mouth disease associated with enterovirus 71 infection in Japan in 1978. Jpn. J. Med. Sci. Biol. 1981;34:191–196. doi: 10.7883/yoken1952.34.191.</Citation><ArticleIdList><ArticleId IdType="doi">10.7883/yoken1952.34.191</ArticleId><ArticleId IdType="pubmed">6273621</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua K.B., Kasri A.R. Hand foot and mouth disease due to enterovirus 71 in Malaysia. Virol. Sin. 2011;26:221–228. doi: 10.1007/s12250-011-3195-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-011-3195-8</ArticleId><ArticleId IdType="pmc">PMC8222466</ArticleId><ArticleId IdType="pubmed">21847753</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim C.T., Jiang L., Ma S., James L., Ang L.W. Basic reproduction number of coxsackievirus type A6 and A16 and enterovirus 71: Estimates from outbreaks of hand, foot and mouth disease in Singapore, a tropical city-state. Epidemiol. Infect. 2016;144:1028–1034. doi: 10.1017/S0950268815002137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268815002137</ArticleId><ArticleId IdType="pubmed">26374168</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek K., Yeo S., Lee B., Park K., Song J., Yu J., Rheem I., Kim J., Hwang S., Choi Y., et al. Epidemics of enterovirus infection in Chungnam Korea, 2008 and 2009. Virol. J. 2011;8:297. doi: 10.1186/1743-422X-8-297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-297</ArticleId><ArticleId IdType="pmc">PMC3130694</ArticleId><ArticleId IdType="pubmed">21668960</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia M.Y., Chiang P.S., Chung W.Y., Luo S.T., Lee M.S. Epidemiology of enterovirus 71 infections in Taiwan. Pediatr. Neonatol. 2014;55:243–249. doi: 10.1016/j.pedneo.2013.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pedneo.2013.07.007</ArticleId><ArticleId IdType="pubmed">24120535</ArticleId></ArticleIdList></Reference><Reference><Citation>Linsuwanon P., Puenpa J., Huang S.W., Wang Y.F., Mauleekoonphairoj J., Wang J.R., Poovorawan Y. Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations. J. Biomed. Sci. 2014;21:16. doi: 10.1186/1423-0127-21-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-16</ArticleId><ArticleId IdType="pmc">PMC3937078</ArticleId><ArticleId IdType="pubmed">24548776</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanh T.H., Sabanathan S., Thanh T.T., Thoa L.P.K., Thuong T.C., Hang V.T., Farrar J.F., Hien T.T., Chau N.V., van Doorn H.R. Enterovirus 71-associated hand, foot, and mouth disease, Southern Vietnam, 2011. Emerg. Infect. Dis. 2012;18:2002–2005. doi: 10.3201/eid1812.120929.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1812.120929</ArticleId><ArticleId IdType="pmc">PMC3557876</ArticleId><ArticleId IdType="pubmed">23194699</ArticleId></ArticleIdList></Reference><Reference><Citation>Puenpa J., Wanlapakorn N., Vongpunsawad S., Poovorawan Y. The history of enterovirus A71 outbreaks and molecular epidemiology in the asia-pacific region. J. Biomed. Sci. 2019;26:75. doi: 10.1186/s12929-019-0573-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0573-2</ArticleId><ArticleId IdType="pmc">PMC6798416</ArticleId><ArticleId IdType="pubmed">31627753</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M.L., Shih S.R., Tolbert B.S., Brewer G. Enterovirus A71 vaccines. Vaccines. 2021;9:199. doi: 10.3390/vaccines9030199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9030199</ArticleId><ArticleId IdType="pmc">PMC7997495</ArticleId><ArticleId IdType="pubmed">33673595</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D., Zhao Y., Kotecha A., Fry E.E., Kelly J.T., Wang X., Rao Z., Rowlands D.J., Ren J., Stuart D.I. Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. Nat. Microbiol. 2019;4:414–419. doi: 10.1038/s41564-018-0319-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0319-z</ArticleId><ArticleId IdType="pubmed">30531980</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangar D.V. The replication of picornaviruses. J. Gen Virol. 1979;45:1–13. doi: 10.1099/0022-1317-45-1-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-45-1-1</ArticleId><ArticleId IdType="pubmed">392052</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.Y., Shih S.R. Cell and tissue tropism of enterovirus 71 and other enteroviruses infections. J. Biomed. Sci. 2014;21:18. doi: 10.1186/1423-0127-21-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-18</ArticleId><ArticleId IdType="pmc">PMC3995930</ArticleId><ArticleId IdType="pubmed">24602216</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.S., Liao C.C., Liou A.T., Chang Y.S., Chang Y.T., Tzeng B.H., Chen C.C., Shih C. Enterovirus 71 targets the cardiopulmonary system in a robust oral infection mouse model. Sci. Rep. 2019;9:11108. doi: 10.1038/s41598-019-47455-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-47455-3</ArticleId><ArticleId IdType="pmc">PMC6668393</ArticleId><ArticleId IdType="pubmed">31366973</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.W., Wang S.W., Tung Y.Y., Chen S.H. Enterovirus 71 infection of human dendritic cells. Exp. Biol. Med. 2009;234:1166–1173. doi: 10.3181/0903-RM-116.</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/0903-RM-116</ArticleId><ArticleId IdType="pubmed">19596831</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H.I., Lin J.Y., Chen S.H. EV71 infection induces IFNβ expression in neural cells. Viruses. 2019;11:1121. doi: 10.3390/v11121121.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11121121</ArticleId><ArticleId IdType="pmc">PMC6950376</ArticleId><ArticleId IdType="pubmed">31817126</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., Koike S. Cellular receptors for enterovirus A71. J. Biomed. Sci. 2020;27:23. doi: 10.1186/s12929-020-0615-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-0615-9</ArticleId><ArticleId IdType="pmc">PMC6954530</ArticleId><ArticleId IdType="pubmed">31924205</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo D., Dopazo J., Vega M.A. The CD36, CLA-1 (CD36L1), and LIMPII (CD36L2) gene family: Cellular distribution, chromosomal location, and genetic evolution. Genomics. 1995;25:100–106. doi: 10.1016/0888-7543(95)80114-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0888-7543(95)80114-2</ArticleId><ArticleId IdType="pubmed">7539776</ArticleId></ArticleIdList></Reference><Reference><Citation>Alquraini A., Khoury J.E. Scavenger receptors. Curr. Biol. 2020;30:R790–R795. doi: 10.1016/j.cub.2020.05.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2020.05.051</ArticleId><ArticleId IdType="pmc">PMC7768803</ArticleId><ArticleId IdType="pubmed">32693066</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Fujii K., Koike S. Receptors for enterovirus 71. Emerg. Microbes Infect. 2014;3:e53. doi: 10.1038/emi.2014.49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2014.49</ArticleId><ArticleId IdType="pmc">PMC4126179</ArticleId><ArticleId IdType="pubmed">26038749</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Chen N., Zhou S., Zheng K., Sun L., Zhang Y., Cao L., Zhang X., Xiang Q., Chen Z., et al. Severity of enterovirus A71 infection in a human SCARB2 knock-in mouse model is dependent on infectious strain and route. Emerg. Microbes Infect. 2018;7:205. doi: 10.1038/s41426-018-0201-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41426-018-0201-3</ArticleId><ArticleId IdType="pmc">PMC6281673</ArticleId><ArticleId IdType="pubmed">30518755</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Yang P., Wang N., Zhang J., Li J., Guo H., Yin X., Rao Z., Wang X., Zhang L. The binding of a monoclonal antibody to the apical region of SCARB2 blocks EV71 infection. Protein Cell. 2017;8:590–600. doi: 10.1007/s13238-017-0405-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-017-0405-7</ArticleId><ArticleId IdType="pmc">PMC5546930</ArticleId><ArticleId IdType="pubmed">28447294</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., Shimizu H. Cellular receptors for human enterovirus species a. Front. Microbiol. 2012;3:105. doi: 10.3389/fmicb.2012.00105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2012.00105</ArticleId><ArticleId IdType="pmc">PMC3313065</ArticleId><ArticleId IdType="pubmed">22470371</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Iizuka S., Yamashita T., Minagawa H., Mizuta K., Okamoto M., Nishimura H., Sanjoh K., Katsushima N., Itagaki T., et al. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J. Virol. 2012;86:5686–5696. doi: 10.1128/JVI.00020-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00020-12</ArticleId><ArticleId IdType="pmc">PMC3347270</ArticleId><ArticleId IdType="pubmed">22438546</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.W., Lin H.Y., Tsou Y.L., Chitra E., Hsiao K.N., Shao H.Y., Liu C.C., Sia C., Chong P., Chow Y.H. Human SCARB2-mediated entry and endocytosis of EV71. PLoS ONE. 2012;7:e30507. doi: 10.1371/journal.pone.0030507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0030507</ArticleId><ArticleId IdType="pmc">PMC3260287</ArticleId><ArticleId IdType="pubmed">22272359</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen T.Y., Shih W.L., Huang Y.C., Lee J.T., Huang L.M., Chang L.Y. Polymorphisms in enterovirus 71 receptors associated with susceptibility and clinical severity. PLoS ONE. 2018;13:e0206769. doi: 10.1371/journal.pone.0206769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0206769</ArticleId><ArticleId IdType="pmc">PMC6218064</ArticleId><ArticleId IdType="pubmed">30395634</ArticleId></ArticleIdList></Reference><Reference><Citation>Laszik Z., Jansen P.J., Cummings R.D., Tedder T.F., McEver R.P., Moore K.L. P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood. 1996;88:3010–3021. doi: 10.1182/blood.V88.8.3010.bloodjournal8883010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V88.8.3010.bloodjournal8883010</ArticleId><ArticleId IdType="pubmed">8874199</ArticleId></ArticleIdList></Reference><Reference><Citation>Somers W.S., Tang J., Shaw G.D., Camphausen R.T. Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1. Cell. 2000;103:467–479. doi: 10.1016/S0092-8674(00)00138-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)00138-0</ArticleId><ArticleId IdType="pubmed">11081633</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., Shimojima M., Tano Y., Miyamura T., Wakita T., Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat. Med. 2009;15:794–797. doi: 10.1038/nm.1961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., Wakita T., Shimizu H. Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection. PLoS Pathog. 2010;6:e1001174. doi: 10.1371/journal.ppat.1001174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001174</ArticleId><ArticleId IdType="pmc">PMC2973824</ArticleId><ArticleId IdType="pubmed">21079683</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., Lee H., Hafenstein S., Kataoka C., Wakita T., Bergelson J.M., Shimizu H. Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. PLoS Pathog. 2013;9:e1003511. doi: 10.1371/journal.ppat.1003511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003511</ArticleId><ArticleId IdType="pmc">PMC3723564</ArticleId><ArticleId IdType="pubmed">23935488</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Tijsma A., Mirabelli C., Baggen J., Wahedi M., Franco D., De Palma A., Leyssen P., Verbeken E., van Kuppeveld F.J.M., et al. Intra-host emergence of an enterovirus A71 variant with enhanced PSGL1 usage and neurovirulence. Emerg. Microbes Infect. 2019;8:1076–1085. doi: 10.1080/22221751.2019.1644142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2019.1644142</ArticleId><ArticleId IdType="pmc">PMC6711088</ArticleId><ArticleId IdType="pubmed">31339457</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A., Müller H., Kuwano Y., Ley K. PSGL-1-dependent myeloid leukocyte activation. J. Leukoc. Biol. 2009;86:1119–1124. doi: 10.1189/jlb.0209117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0209117</ArticleId><ArticleId IdType="pubmed">19703898</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Y.Y., Shi K., Yao S., Yang X., Liu Y.H., Tang L., Dang Y.W., Chen G., Feng Z.B., Pan H.B. Morphological characteristics of fatal pediatric hand, foot and mouth disease: A clinicopathological study with related receptors of EV71. Pathol. Res. Pract. 2017;213:1144–1151. doi: 10.1016/j.prp.2017.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prp.2017.07.004</ArticleId><ArticleId IdType="pubmed">28756983</ArticleId></ArticleIdList></Reference><Reference><Citation>Maginnis M.S. Virus-Receptor Interactions: The Key to Cellular Invasion. J. Mol. Biol. 2018;430:2590–2611. doi: 10.1016/j.jmb.2018.06.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2018.06.024</ArticleId><ArticleId IdType="pmc">PMC6083867</ArticleId><ArticleId IdType="pubmed">29924965</ArticleId></ArticleIdList></Reference><Reference><Citation>Varki N.M., Varki A. Diversity in cell surface sialic acid presentations: Implications for biology and disease. Lab. Investig. 2007;87:851–857. doi: 10.1038/labinvest.3700656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.3700656</ArticleId><ArticleId IdType="pmc">PMC7100186</ArticleId><ArticleId IdType="pubmed">17632542</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B., Chuang H., Yang K.D. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol. J. 2009;6:141. doi: 10.1186/1743-422X-6-141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-6-141</ArticleId><ArticleId IdType="pmc">PMC2751754</ArticleId><ArticleId IdType="pubmed">19751532</ArticleId></ArticleIdList></Reference><Reference><Citation>Rintala-Dempsey A.C., Rezvanpour A., Shaw G.S. S100-annexin complexes--structural insights. FEBS J. 2008;275:4956–4966. doi: 10.1111/j.1742-4658.2008.06654.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2008.06654.x</ArticleId><ArticleId IdType="pubmed">18795951</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.R., Skeate J.G., Kast W.M. Annexin A2 in Virus Infection. Front. Microbiol. 2018;9:2954. doi: 10.3389/fmicb.2018.02954.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.02954</ArticleId><ArticleId IdType="pmc">PMC6290281</ArticleId><ArticleId IdType="pubmed">30568638</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerke V., Moss S.E. Annexins: From structure to function. Physiol. Rev. 2002;82:331–371. doi: 10.1152/physrev.00030.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00030.2001</ArticleId><ArticleId IdType="pubmed">11917092</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S.L., Chou Y.T., Wu C.N., Ho M.S. Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J. Virol. 2011;85:11809–11820. doi: 10.1128/JVI.00297-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00297-11</ArticleId><ArticleId IdType="pmc">PMC3209289</ArticleId><ArticleId IdType="pubmed">21900167</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjellén L., Lindahl U. Proteoglycans: Structures and interactions. Annu. Rev. Biochem. 1991;60:443–475. doi: 10.1146/annurev.bi.60.070191.002303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.bi.60.070191.002303</ArticleId><ArticleId IdType="pubmed">1883201</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarrazin S., Lamanna W.C., Esko J.D. Heparan sulfate proteoglycans. Cold Spring Harb. Perspect. Biol. 2011;3:a004952. doi: 10.1101/cshperspect.a004952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a004952</ArticleId><ArticleId IdType="pmc">PMC3119907</ArticleId><ArticleId IdType="pubmed">21690215</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagno V., Tseligka E.D., Jones S.T., Tapparel C. Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias? Viruses. 2019;11:596. doi: 10.3390/v11070596.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11070596</ArticleId><ArticleId IdType="pmc">PMC6669472</ArticleId><ArticleId IdType="pubmed">31266258</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.W., Poh C.L., Sam I.C., Chan Y.F. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J. Virol. 2013;87:611–620. doi: 10.1128/JVI.02226-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02226-12</ArticleId><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., Sudaka Y., Takashino A., Imura A., Fujii K., Koike S. Amino acid variation at VP1-145 of enterovirus 71 determines attachment receptor usage and neurovirulence in human scavenger receptor B2 transgenic mice. J. Virol. 2018;92:e00681-18. doi: 10.1128/JVI.00681-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00681-18</ArticleId><ArticleId IdType="pmc">PMC6052303</ArticleId><ArticleId IdType="pubmed">29848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Neckers L., Ivy S.P. Heat shock protein 90. Curr. Opin. Oncol. 2003;15:419–424. doi: 10.1097/00001622-200311000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001622-200311000-00003</ArticleId><ArticleId IdType="pubmed">14624223</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsou Y.L., Lin Y.W., Chang H.W., Lin H.Y., Shao H.Y., Yu S.L., Liu C.C., Chitra E., Sia C., Chow Y.H. Heat shock protein 90: Role in enterovirus 71 entry and assembly and potential target for therapy. PLoS ONE. 2013;8:e77133. doi: 10.1371/journal.pone.0077133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0077133</ArticleId><ArticleId IdType="pmc">PMC3788750</ArticleId><ArticleId IdType="pubmed">24098578</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Heitman J. The cyclophilins. Genome Biol. 2005;6:226. doi: 10.1186/gb-2005-6-7-226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2005-6-7-226</ArticleId><ArticleId IdType="pmc">PMC1175980</ArticleId><ArticleId IdType="pubmed">15998457</ArticleId></ArticleIdList></Reference><Reference><Citation>Olejnik P., Nuc K. Cyclophilins—proteins with many functions. Postepy. Biochem. 2018;64:46–54. doi: 10.18388/pb.2018_104. (Article in Polish)</Citation><ArticleIdList><ArticleId IdType="doi">10.18388/pb.2018_104</ArticleId><ArticleId IdType="pubmed">30652836</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D., Mei Q., Li J., He H. Cyclophilin A and viral infections. Biochem. Biophys. Res. Commun. 2012;424:647–650. doi: 10.1016/j.bbrc.2012.07.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2012.07.024</ArticleId><ArticleId IdType="pmc">PMC7092870</ArticleId><ArticleId IdType="pubmed">22814107</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Farmer J.D., Jr., Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991;66:807–815. doi: 10.1016/0092-8674(91)90124-H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(91)90124-H</ArticleId><ArticleId IdType="pubmed">1715244</ArticleId></ArticleIdList></Reference><Reference><Citation>Qing J., Wang Y., Sun Y., Huang J., Yan W., Wang J., Su D., Ni C., Li J., Rao Z., et al. Cyclophilin A associates with enterovirus-71 virus capsid and plays an essential role in viral infection as an uncoating regulator. PLoS Pathog. 2014;10:e1004422. doi: 10.1371/journal.ppat.1004422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004422</ArticleId><ArticleId IdType="pmc">PMC4183573</ArticleId><ArticleId IdType="pubmed">25275585</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman R.D., Khuon S., Chou Y.H., Opal P., Steinert P.M. The function of intermediate filaments in cell shape and cytoskeletal integrity. J. Cell Biol. 1996;134:971–983. doi: 10.1083/jcb.134.4.971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.134.4.971</ArticleId><ArticleId IdType="pmc">PMC2120965</ArticleId><ArticleId IdType="pubmed">8769421</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukhotnik I., Shahar Y.B., Pollak Y., Dorfman T., Shefer H.K., Assi Z.E., Mor-Vaknin N., Coran A.G. The role of intermediate filaments in maintaining integrity and function of intestinal epithelial cells after massive bowel resection in a rat. Pediatr. Surg. Int. 2018;3:217–225. doi: 10.1007/s00383-017-4192-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00383-017-4192-2</ArticleId><ArticleId IdType="pubmed">29043445</ArticleId></ArticleIdList></Reference><Reference><Citation>Du N., Cong H., Tian H., Zhang H., Zhang W., Song L., Tien P. Cell surface vimentin is an attachment receptor for enterovirus 71. J. Virol. 2014;88:5816–5833. doi: 10.1128/JVI.03826-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03826-13</ArticleId><ArticleId IdType="pmc">PMC4019121</ArticleId><ArticleId IdType="pubmed">24623428</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginisty H., Sicard H., Roger B., Bouvet P. Structure and functions of nucleolin. J. Cell Sci. 1999;112:761–772. doi: 10.1242/jcs.112.6.761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.112.6.761</ArticleId><ArticleId IdType="pubmed">10036227</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakeri A., Mastrangelo P., Griffin J.K., Moraes T.J., Hegele R.G. Respiratory syncytial virus receptor expression in the mouse and viral tropism. Histol. Histopathol. 2015;30:401–411.</Citation><ArticleIdList><ArticleId IdType="pubmed">25374027</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrangelo P., Chin A.A., Tan S., Jeon A.H., Ackerley C.A., Siu K.K., Lee J.E., Hegele R.G. Identification of RSV Fusion Protein Interaction Domains on the Virus Receptor, Nucleolin. Viruses. 2021;13:261. doi: 10.3390/v13020261.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020261</ArticleId><ArticleId IdType="pmc">PMC7915953</ArticleId><ArticleId IdType="pubmed">33567674</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovanessian A.G. Midkine, a cytokine that inhibits HIV infection by binding to the cell surface expressed nucleolin. Cell Res. 2006;16:174–181. doi: 10.1038/sj.cr.7310024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cr.7310024</ArticleId><ArticleId IdType="pubmed">16474431</ArticleId></ArticleIdList></Reference><Reference><Citation>Su P.Y., Wang Y.F., Huang S.W., Lo Y.C., Wang Y.H., Wu S.R., Shieh D.B., Chen S.H., Wang J.R., Lai M.D., et al. Cell surface nucleolin facilitates enterovirus 71 binding and infection. J. Virol. 2015;89:4527–4538. doi: 10.1128/JVI.03498-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03498-14</ArticleId><ArticleId IdType="pmc">PMC4442404</ArticleId><ArticleId IdType="pubmed">25673703</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankov R., Yamada K.M. Fibronectin at a glance. J. Cell Sci. 2002;115:3861–3863. doi: 10.1242/jcs.00059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.00059</ArticleId><ArticleId IdType="pubmed">12244123</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams J.C., Chiquet-Ehrismann R., Tucker R.P. The evolution of tenascins and fibronectin. Cell Adh. Migr. 2015;9:22–33. doi: 10.4161/19336918.2014.970030.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/19336918.2014.970030</ArticleId><ArticleId IdType="pmc">PMC4422808</ArticleId><ArticleId IdType="pubmed">25482621</ArticleId></ArticleIdList></Reference><Reference><Citation>He Q.Q., Ren S., Xia Z.C., Cheng Z.K., Peng N.F., Zhu Y. Fibronectin Facilitates Enterovirus 71 Infection by Mediating Viral Entry. J. Virol. 2018;92:e02251-17. doi: 10.1128/JVI.02251-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02251-17</ArticleId><ArticleId IdType="pmc">PMC5899198</ArticleId><ArticleId IdType="pubmed">29467312</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y., Chiang W.C., Sumpter R., Jr., Mishra P., Levine B. Prohibitin 2 Is an Inner Mitochondrial Membrane Mitophagy Receptor. Cell. 2017;168:224–238. doi: 10.1016/j.cell.2016.11.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.11.042</ArticleId><ArticleId IdType="pmc">PMC5235968</ArticleId><ArticleId IdType="pubmed">28017329</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury I., Thompson W.E., Thomas K. Prohibitins role in cellular survival through Ras-Raf-MEK-ERK pathway. J. Cell Physiol. 2014;229:998–1004. doi: 10.1002/jcp.24531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.24531</ArticleId><ArticleId IdType="pmc">PMC4413917</ArticleId><ArticleId IdType="pubmed">24347342</ArticleId></ArticleIdList></Reference><Reference><Citation>Too I.H.K., Bonne I., Tan E.L., Chu J.J.H., Alonso S. Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis. PLoS Pathog. 2018;14:e1006778. doi: 10.1371/journal.ppat.1006778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006778</ArticleId><ArticleId IdType="pmc">PMC5764453</ArticleId><ArticleId IdType="pubmed">29324904</ArticleId></ArticleIdList></Reference><Reference><Citation>Too I.H., Yeo H., Sessions O.M., Yan B., Libau E.A., Howe J.L., Lim Z.Q., Suku-Maran S., Ong W.Y., Chua K.B., et al. Enterovirus 71 infection of motor neuron-like NSC-34 cells undergoes a non-lytic exit pathway. Sci. Rep. 2016;6:36983. doi: 10.1038/srep36983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep36983</ArticleId><ArticleId IdType="pmc">PMC5111112</ArticleId><ArticleId IdType="pubmed">27849036</ArticleId></ArticleIdList></Reference><Reference><Citation>Kisselev L.L. Mammalian tryptophanyl-tRNA synthetases. Biochimie. 1993;75:1027–1039. doi: 10.1016/0300-9084(93)90002-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0300-9084(93)90002-A</ArticleId><ArticleId IdType="pubmed">7515282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung M.L., Jia L., Yip C.C.Y., Chan J.F.W., Teng J.L.L., Chan K.H., Cai J.P., Zhang C., Zhang A.J., Wong W.M., et al. Human tryptophanyl-tRNA synthetase is an IFN-γ-inducible entry factor for Enterovirus. J. Clin. Investig. 2018;128:5163–5177. doi: 10.1172/JCI99411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI99411</ArticleId><ArticleId IdType="pmc">PMC6205371</ArticleId><ArticleId IdType="pubmed">30153112</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan M., Yan J., Xun J., Chen C., Zhang Y., Wang M., Chu W., Song Z., Hu Y., Zhang S., et al. Enhanced human enterovirus 71 infection by endocytosis inhibitors reveals multiple entry pathways by enterovirus causing hand-foot-and-mouth diseases. Virol. J. 2018;15:1. doi: 10.1186/s12985-017-0913-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-017-0913-3</ArticleId><ArticleId IdType="pmc">PMC5751926</ArticleId><ArticleId IdType="pubmed">29298696</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang M., Wang X., Wang Q., Wang Y., Lin J., Sun Y., Li X., Zhang L., Lou Z., Wang J., et al. Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell. 2014;5:692–703. doi: 10.1007/s13238-014-0087-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-014-0087-3</ArticleId><ArticleId IdType="pmc">PMC4145081</ArticleId><ArticleId IdType="pubmed">24986489</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain K.M., Leong K.L., Ng M.M., Chu J.J. The essential role of clathrin-mediated endocytosis in the infectious entry of human enterovirus 71. J. Biol. Chem. 2011;286:309–321. doi: 10.1074/jbc.M110.168468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.168468</ArticleId><ArticleId IdType="pmc">PMC3012988</ArticleId><ArticleId IdType="pubmed">20956521</ArticleId></ArticleIdList></Reference><Reference><Citation>Mudhakir D., Harashima H. Learning from the viral journey: How to enter cells and how to overcome intracellular barriers to reach the nucleus. AAPS J. 2009;11:65–77. doi: 10.1208/s12248-009-9080-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1208/s12248-009-9080-9</ArticleId><ArticleId IdType="pmc">PMC2664881</ArticleId><ArticleId IdType="pubmed">19194803</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H.Y., Yang Y.T., Yu S.L., Hsiao K.N., Liu C.C., Sia C., Chow Y.H. Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infection. J. Virol. 2013;87:9064–9076. doi: 10.1128/JVI.00573-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00573-13</ArticleId><ArticleId IdType="pmc">PMC3754029</ArticleId><ArticleId IdType="pubmed">23760234</ArticleId></ArticleIdList></Reference><Reference><Citation>Parton R.G., Howes M.T. Revisiting caveolin trafficking: The end of the caveosome. J. Cell Biol. 2010;191:439–441. doi: 10.1083/jcb.201009093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201009093</ArticleId><ArticleId IdType="pmc">PMC3003311</ArticleId><ArticleId IdType="pubmed">21041440</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayer A., Stoeber M., Ritz D., Engel S., Meyer H.H., Helenius A. Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation. J. Cell Biol. 2010;191:615–629. doi: 10.1083/jcb.201003086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201003086</ArticleId><ArticleId IdType="pmc">PMC3003328</ArticleId><ArticleId IdType="pubmed">21041450</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S.L., Liu Y.G., Zhou Y.T., Zhao P., Ren H., Xiao M., Zhu Y.Z., Qi Z.T. Endophilin-A2-mediated endocytic pathway is critical for enterovirus 71 entry into caco-2 cells. Emerg. Microbes Infect. 2019;8:773–786. doi: 10.1080/22221751.2019.1618686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2019.1618686</ArticleId><ArticleId IdType="pmc">PMC6542187</ArticleId><ArticleId IdType="pubmed">31132962</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung W.H., Lee I.T., Hsieh H.L., Yang C.M. EV71 induces COX-2 expression via c-Src/PDGFR/PI3K/Akt/p42/p44 MAPK/AP-1 and NF-kappaB in rat brain astrocytes. J. Cell Physiol. 2010;224:376–386. doi: 10.1002/jcp.22133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.22133</ArticleId><ArticleId IdType="pubmed">20333648</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian L., Wang Y., Liu Q., Xia J., Long J.E. Prediction of signaling pathways involved in enterovirus 71 infection by algorithm analysis based on miRNA profiles and their target genes. Arch. Virol. 2015;160:173–182. doi: 10.1007/s00705-014-2249-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-014-2249-2</ArticleId><ArticleId IdType="pubmed">25287131</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu F., Zhao J., Xi X. Identification of genes involved in enterovirus 71 infected SK-N-SH cells. Int. J. Clin. Exp. Pathol. 2017;1:11588–11595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6966083</ArticleId><ArticleId IdType="pubmed">31966515</ArticleId></ArticleIdList></Reference><Reference><Citation>Pleschka S. RNA viruses and the mitogenic Raf/MEK/ERK signal transduction cascade. Biol. Chem. 2008;389:1273–1282. doi: 10.1515/BC.2008.145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/BC.2008.145</ArticleId><ArticleId IdType="pubmed">18713014</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi W., Hou X., Peng H., Zhang L., Li Y., Gu Z., Jiang Q., Shi M., Ji Y., Jiang J. MEK/ERK signaling pathway is required for enterovirus 71 replication in immature dendritic cells. Virol. J. 2014;11:227. doi: 10.1186/s12985-014-0227-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-014-0227-7</ArticleId><ArticleId IdType="pmc">PMC4304142</ArticleId><ArticleId IdType="pubmed">25548009</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Wang P., Chen X., Wang W., Jin Y. Saururus chinensis (Lour.) Baill blocks enterovirus 71 infection by hijacking MEK1-ERK signaling pathway. Antivir. Res. 2015;119:47–56. doi: 10.1016/j.antiviral.2015.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2015.04.009</ArticleId><ArticleId IdType="pubmed">25912818</ArticleId></ArticleIdList></Reference><Reference><Citation>Plotnikov A., Zehorai E., Procaccia S., Seger R. The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim. Biophys. Acta. 2011;1813:1619–1633. doi: 10.1016/j.bbamcr.2010.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2010.12.012</ArticleId><ArticleId IdType="pubmed">21167873</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi W., Hou X., Li X., Peng H., Shi M., Jiang Q., Liu X., Ji Y., Yao Y., He C., et al. Differential gene expressions of the MAPK signaling pathway in enterovirus 71-infected rhabdomyosarcoma cells. Braz. J. Infect. Dis. 2013;17:410–417. doi: 10.1016/j.bjid.2012.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjid.2012.11.009</ArticleId><ArticleId IdType="pmc">PMC9428059</ArticleId><ArticleId IdType="pubmed">23797008</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong W.R., Chen Y.Y., Yang S.M., Chen Y.L., Horng J.T. Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71. Life Sci. 2005;78:82–90. doi: 10.1016/j.lfs.2005.04.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2005.04.076</ArticleId><ArticleId IdType="pmc">PMC7094582</ArticleId><ArticleId IdType="pubmed">16150462</ArticleId></ArticleIdList></Reference><Reference><Citation>Diehl N., Schaal H. Make yourself at home: Viral hijacking of the PI3K/Akt signaling pathway. Viruses. 2013;5:3192–3212. doi: 10.3390/v5123192.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v5123192</ArticleId><ArticleId IdType="pmc">PMC3967167</ArticleId><ArticleId IdType="pubmed">24351799</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji W.T., Liu H.J. PI3K-Akt signaling and viral infection. Recent Pat. Biotechnol. 2008;2:218–226. doi: 10.2174/187220808786241042.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187220808786241042</ArticleId><ArticleId IdType="pubmed">19097333</ArticleId></ArticleIdList></Reference><Reference><Citation>Eaton H.E., Saffran H.A., Wu F.W., Quach K., Smiley J.R. Herpes simplex virus protein kinases US3 and UL13 modulate VP11/12 phosphorylation, virion packaging, and phosphatidylinositol 3-kinase/Akt signaling activity. J. Virol. 2014;88:7379–7388. doi: 10.1128/JVI.00712-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00712-14</ArticleId><ArticleId IdType="pmc">PMC4054420</ArticleId><ArticleId IdType="pubmed">24741093</ArticleId></ArticleIdList></Reference><Reference><Citation>Izmailyan R., Hsao J.C., Chung C.S., Chen C.H., Su P.W., Liao C.L., Chang W. Integrin β1 mediates vaccinia virus entry through activation of PI3K/Akt signaling. J. Virol. 2012;86:6677–6687. doi: 10.1128/JVI.06860-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06860-11</ArticleId><ArticleId IdType="pmc">PMC3393588</ArticleId><ArticleId IdType="pubmed">22496232</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Xie T., Mo G., Zhang Z., Lin L., Zhang X. ACSL1 Inhibits ALV-J Replication by IFN-I Signaling and PI3K/Akt Pathway. Front. Immunol. 2021;12:774323. doi: 10.3389/fimmu.2021.774323.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.774323</ArticleId><ArticleId IdType="pmc">PMC8585972</ArticleId><ArticleId IdType="pubmed">34777393</ArticleId></ArticleIdList></Reference><Reference><Citation>Gongora C., Mechti N. Interferon signaling pathways. Bull. Cancer. 1999;86:911–919. (Article in French)</Citation><ArticleIdList><ArticleId IdType="pubmed">10586107</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen W., Qi Z., Wang J. The function and mechanism of enterovirus 71 (EV71) 3C protease. Curr. Microbiol. 2020;77:968–1975. doi: 10.1007/s00284-020-02082-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00284-020-02082-4</ArticleId><ArticleId IdType="pubmed">32556480</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser L.J., Langereis M.A., Rabouw H.H., Wahedi M., Muntjewerff E.M., de Groot R.J., van Kuppeveld F.J.M. Essential role of enterovirus 2A protease in counteracting stress granule formation and the induction of type I interferon. J. Virol. 2019;93:e00222-19. doi: 10.1128/JVI.00222-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00222-19</ArticleId><ArticleId IdType="pmc">PMC6498061</ArticleId><ArticleId IdType="pubmed">30867299</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Sun M., Yuan X., Ji L., Jin Y., Cardona C.J., Xing Z. Enterovirus 71 suppresses interferon responses by blocking Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling through inducing karyopherin-α1 degradation. J. Biol Chem. 2017;292:10262–10274. doi: 10.1074/jbc.M116.745729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.745729</ArticleId><ArticleId IdType="pmc">PMC5473229</ArticleId><ArticleId IdType="pubmed">28455446</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Chen S., Zhang W., Zhang C., Sun T., Du Y., Ding R., Gao Y., Jin Y., Duan G. MicroRNA-628-5p facilitates enterovirus 71 infection by suppressing TRAF3 signaling. Cell Mol. Immunol. 2021;18:1320–1322. doi: 10.1038/s41423-020-0453-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0453-4</ArticleId><ArticleId IdType="pmc">PMC8093227</ArticleId><ArticleId IdType="pubmed">32398803</ArticleId></ArticleIdList></Reference><Reference><Citation>Good C., Wells A.I., Coyne C.B. Type III interferon signaling restricts enterovirus 71 infection of goblet cells. Sci. Adv. 2019;5:eaau4255. doi: 10.1126/sciadv.aau4255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aau4255</ArticleId><ArticleId IdType="pmc">PMC6402847</ArticleId><ArticleId IdType="pubmed">30854425</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvansakul M. Viral infection and apoptosis. Viruses. 2017;9:356. doi: 10.3390/v9120356.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v9120356</ArticleId><ArticleId IdType="pmc">PMC5744131</ArticleId><ArticleId IdType="pubmed">29168732</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu T., Li Y., Wu H.L., Chen H., Wu H., Guo M., Zhao M., Wang C., Lin T., Lin Z., et al. The inhibition of enterovirus 71 induced apoptosis by Durvillaea antarctica through P53 and STAT1 signaling pathway. J. Med. Virol. 2021;93:3532–3538. doi: 10.1002/jmv.26693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26693</ArticleId><ArticleId IdType="pubmed">33230830</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Z., Li Y., Xu T., Guo M., Wang C., Zhao M., Chen H., Kuang J., Li W., Zhang Y., et al. Inhibition of enterovirus 71 by selenium nanoparticles loaded with siRNA through bax signaling pathways. ACS. Omega. 2020;13:12495–12500. doi: 10.1021/acsomega.0c01382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.0c01382</ArticleId><ArticleId IdType="pmc">PMC7271353</ArticleId><ArticleId IdType="pubmed">32548434</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao J., Lin E., He L., Yu J., Tan P., Zhou Y. Autophagy and viral infection. Adv. Exp. Med. Biol. 2019;1209:55–78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7122562</ArticleId><ArticleId IdType="pubmed">31728865</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z.W., Zhuang Z.C., Chen R., Wang X.R., Zhang H.L., Li S.H., Wang Z.Y., Wen H.L. Enterovirus 71 VP1 protein regulates viral replication in SH-SY5Y cells via the mTOR autophagy signaling pathway. Viruses. 2019;12:11. doi: 10.3390/v12010011.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12010011</ArticleId><ArticleId IdType="pmc">PMC7019657</ArticleId><ArticleId IdType="pubmed">31861844</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.W., Yu S.L., Shao H.Y., Lin H.Y., Liu C.C., Hsiao K.N., Chitra E., Tsou Y.L., Chang H.W., Sia C., et al. Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71. PLoS ONE. 2013;8:e57591. doi: 10.1371/journal.pone.0057591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057591</ArticleId><ArticleId IdType="pmc">PMC3581494</ArticleId><ArticleId IdType="pubmed">23451246</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K., Nagata N., Sato Y., Ong K.C., Wong K.T., Yamayoshi S., Shimanuki M., Shitara H., Taya C., Koike S. Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc. Natl. Acad. Sci. USA. 2013;110:14753–14758. doi: 10.1073/pnas.1217563110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1217563110</ArticleId><ArticleId IdType="pmc">PMC3767555</ArticleId><ArticleId IdType="pubmed">23959904</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourianfar H.R., Poh C.L., Fecondo J., Grollo L. In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71. Virus Res. 2012;169:22–29. doi: 10.1016/j.virusres.2012.06.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2012.06.025</ArticleId><ArticleId IdType="pubmed">22771616</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., Mizuta K., Koike S. Heparan sulfate attachment receptor is a major selection factor for attenuated enterovirus 71 mutants during cell culture adaptation. PLoS Pathog. 2020;16:e1008428. doi: 10.1371/journal.ppat.1008428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008428</ArticleId><ArticleId IdType="pmc">PMC7105141</ArticleId><ArticleId IdType="pubmed">32187235</ArticleId></ArticleIdList></Reference><Reference><Citation>Su P.Y., Liu Y.T., Chang H.Y., Huang S.W., Wang Y.F., Yu C.K., Wang J.R., Chang C.F. Cell surface sialylation affects binding of enterovirus 71 to rhabdomyosarcoma and neuroblastoma cells. BMC Microbiol. 2012;12:162. doi: 10.1186/1471-2180-12-162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-12-162</ArticleId><ArticleId IdType="pmc">PMC3478995</ArticleId><ArticleId IdType="pubmed">22853823</ArticleId></ArticleIdList></Reference><Reference><Citation>Masomian M., Lalani S., Poh C.L. Molecular Docking of SP40 Peptide towards Cellular Receptors for Enterovirus 71 (EV-A71) Molecules. 2021;26:6576. doi: 10.3390/molecules26216576.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26216576</ArticleId><ArticleId IdType="pmc">PMC8587434</ArticleId><ArticleId IdType="pubmed">34770987</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalani S., Tan S.H., Tan K.O., Lim H.X., Ong K.C., Wong K.T., Poh C.L. Molecular mechanism of L-SP40 peptide and in vivo efficacy against EV-A71 in neonatal mice. Life Sci. 2021;287:120097. doi: 10.1016/j.lfs.2021.120097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.120097</ArticleId><ArticleId IdType="pubmed">34715144</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.W., Chan Y.F., Sim K.M., Tan E.L., Poh C.L. Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1. PLoS ONE. 2012;7:e34589. doi: 10.1371/journal.pone.0034589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034589</ArticleId><ArticleId IdType="pmc">PMC3341398</ArticleId><ArticleId IdType="pubmed">22563456</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlutti F., Pantanella F., Natalizi T., Frioni A., Paesano R., Polimeni A., Valenti P. Antiviral properties of lactoferrin--a natural immunity molecule. Molecules. 2011;16:6992–7018. doi: 10.3390/molecules16086992.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules16086992</ArticleId><ArticleId IdType="pmc">PMC6264778</ArticleId><ArticleId IdType="pubmed">21847071</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoshin A.A., Shpichka A.I., Huang G., Chen K., Lu P., Svistunov A.A., Lychagin A.V., Lipina M.M., Sinelnikov M.Y., Reshetov I.V., et al. Lactoferrin as a regenerative agent: The old-new panacea. Pharmacol. Res. 2021;167:105564. doi: 10.1016/j.phrs.2021.105564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2021.105564</ArticleId><ArticleId IdType="pubmed">33744427</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T.Y., Chu C., Chiu C.H. Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro. J. Infect. Dis. 2002;186:1161–1164. doi: 10.1086/343809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/343809</ArticleId><ArticleId IdType="pubmed">12355368</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng T.Y., Chen L.C., Shyu H.W., Chen S.H., Wang J.R., Yu C.K., Lei H.Y., Yeh T.M. Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells. Antivir. Res. 2005;67:31–34. doi: 10.1016/j.antiviral.2005.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2005.03.005</ArticleId><ArticleId IdType="pubmed">15916817</ArticleId></ArticleIdList></Reference><Reference><Citation>Swain S.P., Mohanty S. Imidazolidinones and Imidazolidine-2,4-diones as Antiviral Agents. ChemMedChem. 2019;14:291–302. doi: 10.1002/cmdc.201800686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cmdc.201800686</ArticleId><ArticleId IdType="pubmed">30600644</ArticleId></ArticleIdList></Reference><Reference><Citation>Dove A.W., Racaniello V.R. An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures. J. Virol. 2000;74:3929–3931. doi: 10.1128/JVI.74.8.3929-3931.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.8.3929-3931.2000</ArticleId><ArticleId IdType="pmc">PMC111905</ArticleId><ArticleId IdType="pubmed">10729171</ArticleId></ArticleIdList></Reference><Reference><Citation>Shia K.-S., Li W.-T., Chang C.-M., Hsu M.-C., Chern J.-H., Leong M.K., Tseng S.-N., Lee C.-C., Lee Y.-C., Chen S.-J., et al. Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: A novel class of potent and selective human enterovirus 71 inhibitors. J. Med. Chem. 2002;45:1644–1655. doi: 10.1021/jm010536a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm010536a</ArticleId><ArticleId IdType="pubmed">11931618</ArticleId></ArticleIdList></Reference><Reference><Citation>Chern J.-H., Shia K.-S., Hsu T.-A., Tai C.-L., Lee C.-C., Lee Y.-C., Chang C.-S., Tseng S.-N., Shih S.-R. Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d] pyrimidines: A novel class of potent enterovirus inhibitors. Bioorg. Med. Chem. Lett. 2004;14:2519–2525. doi: 10.1016/j.bmcl.2004.02.092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2004.02.092</ArticleId><ArticleId IdType="pubmed">15109643</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P., Perera R., Yap M.L., Cardosa J., Kuhn R.J., Rossmann M.G. Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc. Natl. Acad. Sci. USA. 2013;110:5463–5467. doi: 10.1073/pnas.1222379110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222379110</ArticleId><ArticleId IdType="pmc">PMC3619292</ArticleId><ArticleId IdType="pubmed">23509286</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih S.-R., Tsai M.-C., Tseng S.-N., Won K.-F., Shia K.-S., Li W.-T., Chern J.-H., Chen G.-W., Lee C.-C., Lee Y.-C., et al. Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone. Antimicrob. Agents Chemother. 2004;48:3523–3529. doi: 10.1128/AAC.48.9.3523-3529.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.48.9.3523-3529.2004</ArticleId><ArticleId IdType="pmc">PMC514779</ArticleId><ArticleId IdType="pubmed">15328120</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T.-C., Liu S.-C., Huang P.-N., Chang H.-Y., Chern J.-H., Shih S.-R.J. Antiviral activity of pyridyl imidazolidinones against enterovirus 71 variants. Biomed. Sci. 2008;15:291–300. doi: 10.1007/s11373-007-9228-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11373-007-9228-5</ArticleId><ArticleId IdType="pubmed">18196474</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y.W., Yam W.K., Kooi R.J.W., Westman J., Arbrandt G., Chu J.J.H. Novel capsid binder and PI4KIIIbeta inhibitors for EV-A71 replication inhibition. Sci. Rep. 2021;11:9719. doi: 10.1038/s41598-021-89271-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-89271-8</ArticleId><ArticleId IdType="pmc">PMC8102518</ArticleId><ArticleId IdType="pubmed">33958691</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G., Zhou F., Gu B., Ding C., Feng D., Xie F., Wang J., Zhang C., Cao Q., Deng Y., et al. In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection. Arch. Virol. 2012;157:669–679. doi: 10.1007/s00705-011-1222-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-011-1222-6</ArticleId><ArticleId IdType="pubmed">22245989</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnard D.L., Hubbard V.D., Smee D.F., Sidwell R.W., Watson K.G., Tucker S.P., Reece P.A. In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: Novel capsid-binding inhibitors with potent antipicornavirus activity. Antimicrob. Agents Chemother. 2004;48:1766–1772. doi: 10.1128/AAC.48.5.1766-1772.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.48.5.1766-1772.2004</ArticleId><ArticleId IdType="pmc">PMC400527</ArticleId><ArticleId IdType="pubmed">15105133</ArticleId></ArticleIdList></Reference><Reference><Citation>Tijsma A., Franco D., Tucker S., Hilgenfeld R., Froeyen M., Leyssen P., Neyts J. The capsid binder Vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replication. Antimicrob. Agents Chemother. 2014;58:6990–6992. doi: 10.1128/AAC.03328-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.03328-14</ArticleId><ArticleId IdType="pmc">PMC4249361</ArticleId><ArticleId IdType="pubmed">25199773</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M., Wakita T., Shimizu H. Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity. J. Gen. Virol. 2008;89:2518–2530. doi: 10.1099/vir.0.2008/002915-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.2008/002915-0</ArticleId><ArticleId IdType="pubmed">18796721</ArticleId></ArticleIdList></Reference><Reference><Citation>Leiro J.M., Castro R., Arranz J.A., Lamas J. Immunomodulating activities of acidic sulphated polysaccharides obtained from the seaweed Ulva rigida C. Agardh. Int. Immunopharmacol. 2007;7:879–888. doi: 10.1016/j.intimp.2007.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2007.02.007</ArticleId><ArticleId IdType="pubmed">17499190</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi H., Zhang Q., Zhao T., Chen R., Zhang H., Niu X., Li Z. Antioxidant activity of different sulfate content derivatives of polysaccharide extracted from Ulva pertusa (Chlorophyta) in vitro. Int. J. Biol. Macromol. 2005;37:195–199. doi: 10.1016/j.ijbiomac.2005.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2005.10.008</ArticleId><ArticleId IdType="pubmed">16310843</ArticleId></ArticleIdList></Reference><Reference><Citation>Berteau O., Mulloy B. Sulfated fucans, fresh perspectives: Structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide. Glycobiology. 2003;13:29R–40R. doi: 10.1093/glycob/cwg058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cwg058</ArticleId><ArticleId IdType="pubmed">12626402</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu H., Chan Y.L., Tsai L.W., Li T.L., Wu C.J. Prevention of human enterovirus 71 infection by kappa carrageenan. Antivir. Res. 2012;95:128–134. doi: 10.1016/j.antiviral.2012.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.05.009</ArticleId><ArticleId IdType="pubmed">22643729</ArticleId></ArticleIdList></Reference><Reference><Citation>Groult H., Cousin R., Chot-Plassot C., Maura M., Bridiau N., Piot J.M., Maugard T., Fruitier-Arnaudin I. λ-Carrageenan Oligosaccharides of Distinct Anti-Heparanase and Anticoagulant Activities Inhibit MDA-MB-231 Breast Cancer Cell Migration. Mar. Drugs. 2019;17:140. doi: 10.3390/md17030140.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md17030140</ArticleId><ArticleId IdType="pmc">PMC6471403</ArticleId><ArticleId IdType="pubmed">30818840</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng K.C., Hsu B.Y., Ling P., Lu W.W., Lin C.W., Kung S.H. Antidepressant Sertraline Is a Broad-Spectrum Inhibitor of Enteroviruses Targeting Viral Entry through Neutralization of Endolysosomal Acidification. Viruses. 2022;14:109. doi: 10.3390/v14010109.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14010109</ArticleId><ArticleId IdType="pmc">PMC8780434</ArticleId><ArticleId IdType="pubmed">35062313</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Meng Q., Li Q., Liu J., Zhou M., Jin Z., Zhao K. Chitosan Derivatives and Their Application in Biomedicine. Int. J. Mol. Sci. 2020;21:487. doi: 10.3390/ijms21020487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21020487</ArticleId><ArticleId IdType="pmc">PMC7014278</ArticleId><ArticleId IdType="pubmed">31940963</ArticleId></ArticleIdList></Reference><Reference><Citation>Thangavelu A., Stelin K.S., Vannala V., Mahabob N., Hayyan F.M.B., Sundaram R. An Overview of Chitosan and Its Role in Periodontics. J. Pharm. Bioallied Sci. 2021;13:S15–S18. doi: 10.4103/jpbs.JPBS_701_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jpbs.JPBS_701_20</ArticleId><ArticleId IdType="pmc">PMC8375799</ArticleId><ArticleId IdType="pubmed">34447035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.C., Lin S.T., Chen C.Y., Wu S.C. Enterovirus 71 adsorption on metal ion-composite chitosan beads. Biotechnol. Prog. 2012;28:206–214. doi: 10.1002/btpr.699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/btpr.699</ArticleId><ArticleId IdType="pubmed">21936063</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Q., Xu Z.C., Zhang F., Cai Y., Chen Y.N., Lu B.J., Zhou H.B., Lan K., Wu S.W. Identification of a novel binding inhibitor that blocks the interaction between hSCARB2 and VP1 of enterovirus 71. Cell Insight. 2022;1:100016. doi: 10.1016/j.cellin.2022.100016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellin.2022.100016</ArticleId><ArticleId IdType="pmc">PMC10120312</ArticleId><ArticleId IdType="pubmed">37193133</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo H.J., Kang H.J., Jung H.J., Kim K., Lim C.J., Park E.H. Anti-inflammatory, anti-angiogenic and anti-nociceptive activities of Saururus chinensis extract. J. Ethnopharmacol. 2008;120:282–286. doi: 10.1016/j.jep.2008.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2008.08.016</ArticleId><ArticleId IdType="pubmed">18790036</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho H.Y., Cho C.W., Song Y.S. Antioxidative and anti-inflammatory effects of Saururus chinensis methanol extract in RAW 264.7 macrophages. J. Med. Food. 2005;8:190–197.</Citation><ArticleIdList><ArticleId IdType="pubmed">16117611</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Q.Z., Xiao D., Feng F., Wen X.D., Wei Q. Ent-Sauchinone as Potential Anticancer Agent Inhibiting Migration and Invasion of Human Liver Cancer Cells via Suppressing the STAT3 Signaling Pathway. Chem. Biodivers. 2018;15:e1800024. doi: 10.1002/cbdv.201800024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbdv.201800024</ArticleId><ArticleId IdType="pubmed">29495104</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.S., Bang O.S., Kim J. Screening of Stat3 inhibitory effects of Korean herbal medicines in the A549 human lung cancer cell line. Integr. Med. Res. 2014;3:67–73. doi: 10.1016/j.imr.2013.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imr.2013.10.004</ArticleId><ArticleId IdType="pmc">PMC5481713</ArticleId><ArticleId IdType="pubmed">28664080</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian L., Li X.Y., Xu Y.X., Li E. Effect and mechanism of Saururus chinensis against herpes dimplex virus. Zhongguo Zhong Yao Za Zhi China J. Chin. Mater. Med. 2012;37:1642–1645. (In Chinese)</Citation><ArticleIdList><ArticleId IdType="pubmed">22993999</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Zhang H., Zhu M., Luo Z., Peng Y. MEK1-ERKs signal cascade is required for the replication of Enterovirus 71 (EV71) Antivir. Res. 2012;93:110–117. doi: 10.1016/j.antiviral.2011.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2011.11.001</ArticleId><ArticleId IdType="pubmed">22101247</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H.Q., Zhang D.J., Ge M., Li Z.R., Jiang J.D., Li Y.H. Formononetin inhibits enterovirus 71 replication by regulating COX-2/PGE₂ expression. Virol. J. 2015;12:35. doi: 10.1186/s12985-015-0264-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-015-0264-x</ArticleId><ArticleId IdType="pmc">PMC4351682</ArticleId><ArticleId IdType="pubmed">25890183</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Zhao B., Chen X., Song N., Wu J., Li G., Yu P., Han Y., Liu J., Qin C. GS-9620 inhibits enterovirus 71 replication mainly through the NF-κB and PI3K-AKT signaling pathways. Antivir. Res. 2018;153:39–48. doi: 10.1016/j.antiviral.2018.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2018.02.002</ArticleId><ArticleId IdType="pubmed">29425831</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Li K., Ma L., Wu S., Hu J., Yan H., Jiang J., Li Y. Berberine inhibits enterovirus 71 replication by downregulating the MEK/ERK signaling pathway and autophagy. Virol. J. 2017;14:2. doi: 10.1186/s12985-016-0674-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-016-0674-4</ArticleId><ArticleId IdType="pmc">PMC5234143</ArticleId><ArticleId IdType="pubmed">28081706</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M., Zheng R., Wu H.L., Chen D., Su J., Xu T., Wu H., Xiang W., Li Y., Zhu B. Inhibition of enterovirus 71 infection by polysaccharides extracted from Picochlorum sp. 122 via the AKT and ATM/ATR signaling pathways. Arch. Virol. 2021;166:3269–3274. doi: 10.1007/s00705-021-05229-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-021-05229-1</ArticleId><ArticleId IdType="pubmed">34536128</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripa I., Andreu S., López-Guerrero J.A., Bello-Morales R. Membrane R: Portals for viral entry. Front. Microbiol. 2021;12:e631274. doi: 10.3389/fmicb.2021.631274.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.631274</ArticleId><ArticleId IdType="pmc">PMC7890030</ArticleId><ArticleId IdType="pubmed">33613502</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y.Z., Wu D.G., Ren H., Xu Q.Q., Zheng K.C., Chen W., Chen S.L., Qian X.J., Tao Q.Y., Wang Y., et al. The role of lipid rafts in the early stage of Enterovirus 71 infection. Cell Physiol. Biochem. 2015;35:1347–1359. doi: 10.1159/000373956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000373956</ArticleId><ArticleId IdType="pubmed">25720437</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang G.H., Luo Y.J., Wu X.Y., Si B.Y., Lin L., Zhu Q.Y. Monoclonal antibody induced with inactived EV71-Hn2 virus protects mice against lethal EV71-Hn2 virus infection. Virol. J. 2010;7:106. doi: 10.1186/1743-422X-7-106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-106</ArticleId><ArticleId IdType="pmc">PMC2887433</ArticleId><ArticleId IdType="pubmed">20500892</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku Z., Ye X., Shi J., Wang X., Liu Q., Huang Z. Single neutralizing monoclonal antibodies targeting the VP1 GH loop of enterovirus 71 inhibit both virus attachment and internalization during viral entry. J. Virol. 2015;89:12084–12095. doi: 10.1128/JVI.02189-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02189-15</ArticleId><ArticleId IdType="pmc">PMC4645313</ArticleId><ArticleId IdType="pubmed">26401034</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H., Cifuente J.O., Ashley R.E., Conway J.F., Makhov A.M., Tano Y., Shimizu H., Nishimura Y., Hafenstein S. A strain-specific epitope of enterovirus 71 identified by cryo-electron microscopy of the complex with fab from neutralizing antibody. J. Virol. 2013;87:11363–11370. doi: 10.1128/JVI.01926-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01926-13</ArticleId><ArticleId IdType="pmc">PMC3807339</ArticleId><ArticleId IdType="pubmed">23946455</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim X.F., Jia Q., Khong W.X., Yan B., Premanand B., Alonso S., Chow V.T., Kwang J. Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection. PLoS ONE. 2012;7:e29751. doi: 10.1371/journal.pone.0029751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0029751</ArticleId><ArticleId IdType="pmc">PMC3261156</ArticleId><ArticleId IdType="pubmed">22279543</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiener T.K., Jia Q., Meng T., Chow V.T., Kwang J. A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved “knob” region of VP3 protein. PLoS Negl. Trop. Dis. 2014;8:e2895. doi: 10.1371/journal.pntd.0002895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002895</ArticleId><ArticleId IdType="pmc">PMC4038473</ArticleId><ArticleId IdType="pubmed">24875055</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Huang Y., Sun M., Ji H., Dou H., Hu J., Yan Y., Wang X., Chen L. Honeysuckle-encoded microRNA2911 inhibits Enterovirus 71 replication via targeting VP1 gene. Antivir. Res. 2018;152:117–123. doi: 10.1016/j.antiviral.2018.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2018.02.015</ArticleId><ArticleId IdType="pubmed">29458129</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng C., Fu Y., Chen D., Wang H., Su A., Zhang L., Chang L., Zheng N., Wu Z. miR-127-5p negatively regulates enterovirus 71 replication by directly targeting SCARB2. FEBS Open Bio. 2017;7:747–758. doi: 10.1002/2211-5463.12197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/2211-5463.12197</ArticleId><ArticleId IdType="pmc">PMC5458453</ArticleId><ArticleId IdType="pubmed">28593131</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Song Z., Qi Y., Feng X., Xu N., Sun Y., Wu X., Yao X., Mao Q., Li X., et al. Molecular determinants of enterovirus 71 viral entry: Cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J. Biol. Chem. 2012;287:6406–6420. doi: 10.1074/jbc.M111.301622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.301622</ArticleId><ArticleId IdType="pmc">PMC3307280</ArticleId><ArticleId IdType="pubmed">22219187</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo D., Yu X., Wang D., Li Z., Zhou Y., Xu G., Yuan B., Qin Y., Chen M. SLC35B2 acts in a dual role in the host sulfation required for EV71 infection. J. Virol. 2022;96:e0204221. doi: 10.1128/jvi.02042-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02042-21</ArticleId><ArticleId IdType="pmc">PMC9093107</ArticleId><ArticleId IdType="pubmed">35420441</ArticleId></ArticleIdList></Reference><Reference><Citation>Falah N., Montserret R., Lelogeais V., Schuffenecker I., Lina B., Cortay J.C., Violot S. Blocking human enterovirus 71 replication by targeting viral 2A protease. J. Antimicrob. Chemother. 2012;67:2865–2869. doi: 10.1093/jac/dks304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dks304</ArticleId><ArticleId IdType="pubmed">22865380</ArticleId></ArticleIdList></Reference><Reference><Citation>Diarimalala R.O., Hu M., Wei Y., Hu K. Recent advances of enterovirus 71 3Cpro targeting Inhibitors. Virol. J. 2020;17:173. doi: 10.1186/s12985-020-01430-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-020-01430-x</ArticleId><ArticleId IdType="pmc">PMC7657364</ArticleId><ArticleId IdType="pubmed">33176821</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao C., Xi C., Hu K., Gao W., Cai X., Qin J., Lv S., Du C., Wei Y. Inhibition of enterovirus 71 replication and viral 3C protease by quercetin. Virol. J. 2018;15:116. doi: 10.1186/s12985-018-1023-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-018-1023-6</ArticleId><ArticleId IdType="pmc">PMC6069798</ArticleId><ArticleId IdType="pubmed">30064445</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>